Article info
PDFReview Articles
Antiplatelet Drugs in the Secondary Prevention of Stroke
Citation
Antiplatelet Drugs in the Secondary Prevention of Stroke
Publication history
- First published February 1, 2002.
Online issue publication
February 01, 2018
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2002 BMJ
Other content recommended for you
- Contemporary antiplatelet therapy for secondary stroke prevention: a narrative review of current literature and guidelines
- Review of current and emerging therapies in acute ischemic stroke
- Dual versus mono antiplatelet therapy for acute non-cardioembolic ischaemic stroke or transient ischaemic attack: a systematic review and meta-analysis
- Clopidogrel loading dose versus maintenance dose to treat patients with acute ischaemic stroke in China (CLASS-China): results from a prospective double-blind randomised clinical trial
- The Chinese Stroke Association scientific statement: intravenous thrombolysis in acute ischaemic stroke
- Management of acute ischemic stroke
- Anti-inflammatory approaches to ischaemic stroke prevention
- Precision antiplatelet therapy for the prevention of ischaemic stroke
- Antithrombotic and interventional treatment options in cardioembolic transient ischaemic attack and ischaemic stroke
- Cerebrovascular disease in sickle cell disease